Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Chronic pain occurred after 2nd injection within a month; The pain is persistent as of today (16Jan) limiting the ability to move fully the shoulder.; Initially the pain was permanent extending toward the base of the neck; now a days the pain is observed only when moving the shoulder and is intense when I do a rapid and intense moreover of the shoulder; Pain at the point of injection  in the shoulder that irradiates up to the neck; Pain at the point of injection  in the shoulder that irradiates up to the neck; Pain at the point of injection  in the shoulder that irradiates up to the neck; Getting worse at night and get worse recently; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 06May2021 16:30 (Lot number: EWO165) at the age of 57 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EWO162, Location of injection: Arm Left, Vaccine Administration Time: 08:30 AM), administration date: 15Apr2021, when the patient was 57 years old, for Covid-19 Immunization. The following information was reported: VACCINATION SITE PAIN (non-serious), ARTHRALGIA (non-serious), PAIN (non-serious) all with onset Sep2021, outcome "not recovered" and all described as "Pain at the point of injection  in the shoulder that irradiates up to the neck"; CONDITION AGGRAVATED (non-serious) with onset Sep2021, outcome "not recovered", described as "Getting worse at night and get worse recently"; PAIN (non-serious), outcome "unknown", described as "Chronic pain occurred after 2nd injection within a month"; JOINT RANGE OF MOTION DECREASED (non-serious), outcome "unknown", described as "The pain is persistent as of today (16Jan) limiting the ability to move fully the shoulder."; NECK PAIN (non-serious), outcome "unknown", described as "Initially the pain was permanent extending toward the base of the neck"; ARTHRALGIA (non-serious), outcome "unknown", described as "now a days the pain is observed only when moving the shoulder and is intense when I do a rapid and intense moreover of the shoulder". Therapeutic measures were taken as a result of vaccination site pain, arthralgia, pain, condition aggravated.  Additional Information: Patient did not receive any other vaccines within 4 weeks. Patient did not receive other medications in two weeks. Adverse event: Pain at the point of injection in the shoulder that irradiates up to the neck, Getting worse at night and get worse recently (1 week). No recent physical activities (no sport) could explain the pain. Adverse events start date: Sep2021. The patient was not Recovered. The patient was taken treatment for adverse events. The advil was taken as treatment for adverse event occasionally. Patient was not diagnosed with COVID-19 prior vaccination. Patient has not been tested for COVID-19 since vaccination. The patient was no known allergies.  The patient had no other medical history. Vaccination facility type:. Concomitant drug was None. Patient medical history was None. Relevant test was None. Specific tests was None. Follow-up (24Jan2022): Chronic pain occurred after 2nd injection within a month. The pain is persistent as of today (16Jan) limiting the ability to move fully the shoulder. Initially the pain was permanent extending toward the base of the neck now a days the pain is observed only when moving the shoulder and is intense when I do a rapid and intense moreover of the shoulder.  Follow-Up (27Oct2021): Follow-up attempts are completed. No further information is expected.  Follow-up (24Jan2022): This is a spontaneous follow-up report from a contactable consumer. This consumer reported in response to Non-HCP letter sent which included that Updated information included Patient route of administration and Vaccine facility information was added, other medical information was added.  No follow-up attempts are possible. No further information is expected.